Coverage litigation stemming from COVID-19 has presented handful of jurisprudential surprises:  exclusions have been mostly enforced, protection charges primarily compensated. Whilst policyholders virtually quickly sued their insurers below a wide range of procedures (e.g., CGL, D&O, WC, EPL, Overall health, Party, Company Interruption, and Journey), the litigation expenditures, judgments, and settlements are only now being offered as coated (and compensated) loss to the reinsurance industry. Inevitably, reinsurers and their cedents will disagree as to how and to what extent reinsurance applies to this loss(es). Several of these negotiations are ongoing and may well end result in litigation, primarily in arbitral message boards. Reinsurance disputes involving travel insurance plan and travel safety will possible be far more contentious than any other line of company influenced by COVID-19.

Travel insurance policy is major business, accounting for more than $4B in annual U.S. quality by itself. It supplies a variety of